LIVAGEN

Part of the Khavinson peptide family, this four-amino-acid sequence (Lys-Glu-Asp-Ala) targets liver cell function at the genetic level. Developed by Russian researchers studying organ-specific bioregulators, it's designed to influence how liver cells access and express their DNA. Most research attention comes from gerontology labs investigating age-related decline in hepatic function.

The peptide works by loosening the tightly wound DNA structures inside liver cells, a process called chromatin decondensation. When DNA is packed too tightly, cells can't access important genes needed for normal liver function and repair processes. By helping unwind these genetic packages, Livagen theoretically allows hepatocytes to reactivate dormant cellular programs and restore more youthful metabolic activity.